Liyang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Liyang Wang has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Tzahi Cohen-Karni
Carnegie Mellon University
4 shared publications - Devora Cohen-Karni
College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Greensburg, PA 15601, USA
3 shared publications - Samuel Gershanok
Department of Materials Science and Engineering, Carnegie Mellon University, Pittsburgh PA 15213
3 shared publications - Bryan N. Brown
University of Pittsburgh
2 shared publications - Clint Skillen
Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15260, USA
2 shared publications - Daniel San Roman
Carnegie Mellon University
2 shared publications
Latest Publications
- Open Access
- 23 March 2026
- Published by Wiley in Advanced Electronic Materials
- Vol. 12 (14) , e00885
Chronic Disease Monitoring Using Advanced Compliant Materials for Bioelectronics
Chronic disease arises slowly through complex physiological factors that require continuous monitoring and treatment. Compliant bioelectronics with soft, stretchable, and tissue‐conformal designs allow for in vivo continuous monitoring through electrophysiological, mechanical, and biochemical modalities, while minimizing tissue irritation and immune system response. In this review, we discuss recent progress in material development, device design, and versatile sensing modalities that allow stable long‐term operation in dynamic biological environments. We focus on chronic electrophysiological systems for neural and cardiac recording, mechanical sensing systems for strain and pressure, and electrochemical sensors for molecular biomarkers. In addition, we examine self‐powered bioelectronics based on piezoelectric and triboelectric energy conversion mechanisms that eliminate the requirement for external batteries, whereas multimodal and closed‐loop systems combine sensing with therapeutic feedback. We consider key parameters like material biocompatibility, device flexibility, and long‐term stability that are required for chronic monitoring to maintain stable signal quality over long time periods relevant for clinical recordings. These technologies for compliant bioelectronics enable early disease diagnosis, personalized treatment and continuous intervention for patients, narrowing the gap between laboratory study and routine clinical applications.
- 23 March 2026
- Published by Wiley in Advanced Electronic Materials
- Vol. 12 (14) , e00885
Open AccessChronic Disease Monitoring Using Advanced Compliant Materials for Bioelectronics
Chronic disease arises slowly through complex physiological factors that require continuous monitoring and treatment. Compliant bioelectronics with soft, stretchable, and tissue‐conformal designs allow for in vivo continuous monitoring through electrophysiological, mechanical, and biochemical modalities, while minimizing tissue irritation and immune system response. In this review, we discuss recent progress in material development, device design, and versatile sensing modalities that allow stable long‐term operation in dynamic biological environments. We focus on chronic electrophysiological systems for neural and cardiac recording, mechanical sensing systems for strain and pressure, and electrochemical sensors for molecular biomarkers. In addition, we examine self‐powered bioelectronics based on piezoelectric and triboelectric energy conversion mechanisms that eliminate the requirement for external batteries, whereas multimodal and closed‐loop systems combine sensing with therapeutic feedback. We consider key parameters like material biocompatibility, device flexibility, and long‐term stability that are required for chronic monitoring to maintain stable signal quality over long time periods relevant for clinical recordings. These technologies for compliant bioelectronics enable early disease diagnosis, personalized treatment and continuous intervention for patients, narrowing the gap between laboratory study and routine clinical applications.
- Open Access
Early electrical stimulation promotes functional recovery after volumetric muscle loss
Volumetric muscle loss (VML) injuries overwhelm the inherent regenerative capacity of skeletal muscle, causing persistent functional deficits with no routinely effective therapies. Electrical stimulation (ES) has been shown to preserve muscle structure in other injury models, but technical barriers have prevented daily delivery during the acute post-injury window when critical regenerative programs are established. Here, we developed a fully implantable bioelectronic system with nanoporous platinum-modified electrodes enabling daily therapeutic stimulation and electromyographic recording without repeated anesthesia in a rat tibialis anterior VML model. Animals receiving ES during the acute post-injury period (10 sessions over days 0–14) showed sustained functional improvement, reaching 90% of baseline torque at 8 weeks compared to 71% in unstimulated controls. This recovery reflected enhanced remodeling of injured muscle rather than synergistic muscle compensation. Histological analysis revealed coordinated early increases in vascularization, pro-regenerative macrophages, and satellite cells. These findings establish early ES as a promising intervention for promoting muscle regeneration after catastrophic injury.
Open AccessEarly electrical stimulation promotes functional recovery after volumetric muscle loss
Volumetric muscle loss (VML) injuries overwhelm the inherent regenerative capacity of skeletal muscle, causing persistent functional deficits with no routinely effective therapies. Electrical stimulation (ES) has been shown to preserve muscle structure in other injury models, but technical barriers have prevented daily delivery during the acute post-injury window when critical regenerative programs are established. Here, we developed a fully implantable bioelectronic system with nanoporous platinum-modified electrodes enabling daily therapeutic stimulation and electromyographic recording without repeated anesthesia in a rat tibialis anterior VML model. Animals receiving ES during the acute post-injury period (10 sessions over days 0–14) showed sustained functional improvement, reaching 90% of baseline torque at 8 weeks compared to 71% in unstimulated controls. This recovery reflected enhanced remodeling of injured muscle rather than synergistic muscle compensation. Histological analysis revealed coordinated early increases in vascularization, pro-regenerative macrophages, and satellite cells. These findings establish early ES as a promising intervention for promoting muscle regeneration after catastrophic injury.
- Open Access
- 30 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (22) , eadv2385
Wound state monitoring by multiplexed, electrochemical, real-time, localized, inflammation-tracking nitric oxide sensor (MERLIN)
Nitric oxide (NO) released endogenously by induced NO synthase (iNOS) in macrophages is a key regulatory biomarker for wound inflammation. Detecting NO directly on the wound bed is challenging due to its short half-life time (6 to 50 seconds), low physiological concentration (nanomolar to micromolar), and interferences in the complex wound environment. Here, we present a compliant, multiplexed, electrochemical, real-time, localized, inflammation-tracking NO sensor (MERLIN) array for in vivo spatiotemporal measurement of NO, with high sensitivity (883 ± 283 nanoamperes per micromolar per square centimeter); selectivity against nitrites (~27,900-fold), ascorbic acid (~3800-fold), and uric acid (~6900-fold); and low limit of detection (~8.00 nM). MERLIN spatiotemporally tracked NO on rat skin wounds for 7 days, and results indicated that NO peaks on day 3, in line with previously reported iNOS activity. MERLIN allows spatial mapping of the NO gradient across the wound bed, which can be used to provide diagnostic information to assist wound care.
- 30 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (22) , eadv2385
Open AccessWound state monitoring by multiplexed, electrochemical, real-time, localized, inflammation-tracking nitric oxide sensor (MERLIN)
Nitric oxide (NO) released endogenously by induced NO synthase (iNOS) in macrophages is a key regulatory biomarker for wound inflammation. Detecting NO directly on the wound bed is challenging due to its short half-life time (6 to 50 seconds), low physiological concentration (nanomolar to micromolar), and interferences in the complex wound environment. Here, we present a compliant, multiplexed, electrochemical, real-time, localized, inflammation-tracking NO sensor (MERLIN) array for in vivo spatiotemporal measurement of NO, with high sensitivity (883 ± 283 nanoamperes per micromolar per square centimeter); selectivity against nitrites (~27,900-fold), ascorbic acid (~3800-fold), and uric acid (~6900-fold); and low limit of detection (~8.00 nM). MERLIN spatiotemporally tracked NO on rat skin wounds for 7 days, and results indicated that NO peaks on day 3, in line with previously reported iNOS activity. MERLIN allows spatial mapping of the NO gradient across the wound bed, which can be used to provide diagnostic information to assist wound care.
- Open Access
Wound state monitoring by multiplexed, electrochemical, real-time, localized, inflammation-tracking nitric oxide sensor (MERLIN)
Nitric oxide (NO) released endogenously by induced nitric oxide synthase (iNOS) in macrophages is a key regulatory biomarker for wound inflammation. Detecting NO directly on the wound bed is challenging due to its short half-life time (6 – 50 s), low physiological concentration (nM - µM) and interferences in the complex wound environment. Existing NO sensors suffer from limitations such as rigid substrates, single point of detection and complex measurement setup. Here we present a compliant, multiplexed, electrochemical, real-time, localized, inflammation-tracking nitric oxide sensor (MERLIN) array for in vivo spatiotemporal measurement of NO, with high sensitivity (15.6 ± 5.0 nA/μM for 1.5 mm diameter electrodes), selectivity against nitrites (ca. 27900-fold), ascorbic acid (ca. 3800-fold), and uric acid (ca. 6900-fold), and low limit of detection (8.00 nM). We developed a robust device fabrication protocol, comprehensive and highly reproducible in vitro characterization yielding a consistent device performance deployed for wound healing diagnostics. MERLIN spatiotemporally tracked NO on rat skin wounds for 7 days and results indicated that NO peaks on day 3, in line with previously reported iNOS activity. MERLIN allows spatial mapping of the NO gradient across the wound bed, which can be used to provide diagnostic information to assist wound care.
Open AccessWound state monitoring by multiplexed, electrochemical, real-time, localized, inflammation-tracking nitric oxide sensor (MERLIN)
Nitric oxide (NO) released endogenously by induced nitric oxide synthase (iNOS) in macrophages is a key regulatory biomarker for wound inflammation. Detecting NO directly on the wound bed is challenging due to its short half-life time (6 – 50 s), low physiological concentration (nM - µM) and interferences in the complex wound environment. Existing NO sensors suffer from limitations such as rigid substrates, single point of detection and complex measurement setup. Here we present a compliant, multiplexed, electrochemical, real-time, localized, inflammation-tracking nitric oxide sensor (MERLIN) array for in vivo spatiotemporal measurement of NO, with high sensitivity (15.6 ± 5.0 nA/μM for 1.5 mm diameter electrodes), selectivity against nitrites (ca. 27900-fold), ascorbic acid (ca. 3800-fold), and uric acid (ca. 6900-fold), and low limit of detection (8.00 nM). We developed a robust device fabrication protocol, comprehensive and highly reproducible in vitro characterization yielding a consistent device performance deployed for wound healing diagnostics. MERLIN spatiotemporally tracked NO on rat skin wounds for 7 days and results indicated that NO peaks on day 3, in line with previously reported iNOS activity. MERLIN allows spatial mapping of the NO gradient across the wound bed, which can be used to provide diagnostic information to assist wound care.